Glatiramer acetate

(Copaxone®)

Glatiramer acetate

Drug updated on 11/13/2023

Dosage FormInjection (subcutaneous: 20 mg/ml, 40 mg/ml)
Drug ClassUnknown mechanism of action
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.